The CeBioR network stretches through and beyond the University through prestigious national and international researchers including NHS, industry, consortia and highly QS ranked universities. Our members’ published outputs include work that has been rated as internationally excellent or world leading in terms of originality, significance, and rigour in the Research Excellence Framework, 2014. Some of the external collaborations/funding with the CeBioR are listed:
An investment company that in conjunction with the University of Huddersfield has funded a million pound project to setup the CeBioR and is led by the centre’s director Dr McHugh. The programme will run for five years and will form the core of the centre’s research activities with a focus on the development of translational biomarkers as indicators of disease for the purpose of diagnostics and drug development.
A European drug discovery platform with the goal to transform research quickly into high-quality drug lead molecules. The centre is leading an EU-wide project in collaboration with academic and industrial partners entitled ‘Developing novel targets for the treatment of depression’, which has recently been accepted to the European Lead Factory programme in conjunction with TIPharma, with the goal of identifying a subset compounds for further lead identification and optimization in the drug development process (medicinal chemistry/phenotypic expression).
The Centre works through several NHS partners across the UK with the purpose of understanding disease and improving the lives of many people. One research theme that has been looking to improve the diagnosis and treatment of pain, has been funded through a Pain Relief Foundation grant and the esteemed British Pain Society Clulow Award with Dr McHugh as principal investigator. This research has been adopted to the prestigious National NIHR Portfolio and forms part of a research collaboration between the UK, EU and the US.
Behaviour to neurochemistry
Children's cancer research